, Update: A Report From the American Heart Association. Circulation, vol.137, issue.12, pp.67-492, 2018.
Epidemiology and risk profile of heart failure, Nature reviews Cardiology, vol.8, issue.1, pp.30-41, 2011. ,
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC, Eur Heart J, vol.37, issue.27, pp.2129-200, 2016. ,
Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry, JACC Heart failure, vol.7, issue.1, pp.13-21, 2019. ,
Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF Registry, JACC Heart failure, 2019. ,
Prescribing and up-titration in recently hospitalized heart failure patients attending a disease management program, International journal of cardiology, vol.216, pp.121-128, 2016. ,
Barriers to Adoption of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure: A Mixed-Methods Study, Journal of the American Heart Association, vol.5, issue.3, p.2493, 2016. ,
Treatment with beta-blockers in nurse-led heart failure clinics: titration efficacy and predictors of failure, European journal of heart failure, vol.9, issue.9, pp.910-916, 2007. ,
Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry, European journal of heart failure, vol.20, issue.9, pp.1326-1360, 2018. ,
Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching, Endocrinology, vol.132, issue.5, pp.1961-70, 1993. ,
Effect of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure. Cardiovascular drugs and therapy, vol.22, pp.305-316, 2008. ,
Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial), Journal of the American College of Cardiology, vol.52, issue.12, pp.997-1003, 2008. ,
A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score, Heart, vol.100, issue.2, pp.115-140, 2014. ,
Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) study, Journal of the American College of Cardiology, vol.56, issue.25, pp.2090-100, 2010. ,
Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial, Jama, vol.318, issue.8, pp.713-733, 2017. ,
NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?). Circulation, vol.137, pp.1671-83, 2018. ,
Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction, Journal of the American College of Cardiology, vol.58, issue.18, pp.1881-1890, 2011. ,
Estimating the Long-Term Treatment Benefits of Sacubitril-Valsartan, N Engl J Med, vol.373, issue.23, pp.2289-90, 2015. ,
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial, Lancet, vol.374, issue.9704, pp.1840-1848, 2009. ,
Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry, Eur J Heart Fail, 2018. ,
Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry, Eur J Heart Fail, vol.19, issue.11, pp.1414-1437, 2017. ,
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions, Eur J Heart Fail, vol.18, issue.6, pp.613-638, 2016. ,
Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection Fraction, J Am Coll Cardiol, vol.74, issue.9, pp.1205-1222, 2019. ,
Statistical analysis and handling of missing data in cluster randomized trials: a systematic review, Trials, vol.17, p.72, 2016. ,
Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction, Journal of the American College of Cardiology, vol.6, issue.4, pp.1875-86, 2017. ,
Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial, Eur J Heart Fail, vol.21, issue.3, pp.337-378, 2019. ,
Non-Invasive Lung IMPEDANCE-Guided Preemptive Treatment in Chronic Heart Failure Patients: A Randomized Controlled Trial (IMPEDANCE-HF Trial), Journal of cardiac failure, vol.22, issue.9, pp.713-735, 2016. ,
Lung ultrasound-guided treatment in ambulatory patients with heart failure: a randomized controlled clinical trial (LUS-HF study), Eur J Heart Fail, vol.21, issue.12, pp.1605-1618, 2019. ,
Prognostic Value of Estimated Plasma Volume in Heart Failure, JACC Heart failure, vol.3, issue.11, pp.886-93, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01236515
Prognostic value of estimated plasma volume in acute heart failure in three cohort studies, Clinical research in cardiology : official journal of the German Cardiac Society, 2018. ,
Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHF, J Am Coll Cardiol, vol.71, issue.4, pp.386-98, 2018. ,
Strategy to recognize and initiate treatment of chronic heart failure in primary care (STRETCH): a cluster randomized trial, 34. van Riet EE, Hoes AW, vol.14, p.1, 2014. ,
Rationale, design and baseline results of the Treatment Optimisation in Primary care of Heart failure in the Utrecht region (TOPHU) study: a cluster randomised controlled trial, BMC family practice, vol.16, p.130, 2015. ,
Design of a bilevel clinical trial targeting adherence in heart failure patients and their providers: The Congestive Heart Failure Adherence Redesign Trial (CHART), American heart journal, vol.195, pp.139-50, 2018. ,
Nurse-led titration of angiotensin converting enzyme inhibitors, beta-adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction. The Cochrane database of systematic reviews, vol.2015, p.9889 ,
Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Archives of internal medicine, vol.159, pp.1939-1984, 1999. ,
Effect of selfmonitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial, Jama, vol.312, issue.8, pp.799-808, 2014. ,
Guideline-Directed Medical Therapy Clinics: A Call to Action for the Heart Failure Team, JACC Heart Fail, vol.7, issue.5, pp.442-445, 2019. ,
,
, Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial, J Am Coll Cardiol, vol.43, issue.9, pp.1534-1575, 2004.
Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to ,
, Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial, Circulation, vol.139, pp.2285-2293, 2019.
Improving medication titration in heart failure by embedding a structured medication titration plan, International journal of cardiology, vol.224, pp.99-106, 2016. ,
Potential impact of optimal implementation of evidence-based heart failure therapies on mortality, American heart journal, vol.161, issue.6, pp.1024-1054, 2011. ,
Usefulness of brain natriuretic peptide levels, as compared with usual clinical control ,
, Medicina clinica, vol.135, issue.10, pp.435-475, 2010.
Adding serial Nterminal pro brain natriuretic peptide measurements to optimal clinical management in outpatients with systolic heart failure: a multicentre randomized clinical trial (NorthStar monitoring study), European journal of heart failure, vol.15, issue.7, pp.818-845, 2013. ,
The STARBRITE trial: a randomized, pilot study of B-type natriuretic peptide-guided therapy in patients with advanced heart failure, Journal of cardiac failure, vol.17, issue.8, pp.613-634, 2011. ,
Brain natriuretic peptide-guided treatment does not improve morbidity and mortality in extensively treated patients with chronic heart failure: responders to treatment have a significantly better outcome, European journal of heart failure, vol.13, issue.10, pp.1096-103, 2011. ,
Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations, Lancet, vol.355, issue.9210, pp.1126-1156, 2000. ,
BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial, Jama, vol.301, issue.4, pp.383-92, 2009. ,
N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study, Journal of the American College of Cardiology, vol.55, issue.7, pp.645-53, 2010. ,
Improved pharmacological therapy of chronic heart failure in primary care: a randomized Study of NT-proBNP Guided Management of Heart Failure--SIGNAL-HF (Swedish Intervention study--Guidelines and NT-proBNP AnaLysis in Heart Failure), European journal of heart failure, vol.12, issue.12, pp.1300-1308, 2010. ,
Nterminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial, Journal of the American College of Cardiology, vol.55, issue.1, pp.53-60, 2009. ,
Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study, Journal of the American College of Cardiology, vol.49, issue.16, pp.1733-1742, 2007. ,